Is CONMED Stock a Good Investment?
CONMED Investment Advice | CNMD |
- Examine CONMED's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research CONMED's leadership team and their track record. Good management can help CONMED navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact CONMED's business and its evolving consumer preferences.
- Compare CONMED's performance and market position to its competitors. Analyze how CONMED is positioned in terms of product offerings, innovation, and market share.
- Check if CONMED pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about CONMED's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in CONMED stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if CONMED is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine CONMED Stock
Researching CONMED's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 100.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.89. Some equities with similar Price to Book (P/B) outperform the market in the long run. CONMED has Price/Earnings (P/E) ratio of 188.03. The entity last dividend was issued on the 14th of March 2025. The firm had 3:2 split on the 10th of September 2001.
To determine if CONMED is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding CONMED's research are outlined below:
| CONMED generated a negative expected return over the last 90 days | |
| Over 100.0% of the company shares are held by institutions such as insurance companies |
CONMED uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in CONMED. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CONMED's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 31st of January 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 31st of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
CONMED's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.9 B.CONMED's profitablity analysis
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16.Determining CONMED's profitability involves analyzing its financial statements and using various financial metrics to determine if CONMED is a good buy. For example, gross profit margin measures CONMED's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of CONMED's profitability and make more informed investment decisions.
Please note, the presentation of CONMED's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CONMED's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CONMED's management manipulating its earnings.
Basic technical analysis of CONMED Stock
As of the 19th of March, CONMED shows the risk adjusted performance of (0.07), and Mean Deviation of 1.69. CONMED technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CONMED variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if CONMED is priced favorably, providing market reflects its regular price of 60.61 per share. Given that CONMED has information ratio of (0.05), we suggest you to validate CONMED's prevailing market performance to make sure the company can sustain itself in the future.CONMED's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CONMED insiders, such as employees or executives, is commonly permitted as long as it does not rely on CONMED's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CONMED insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
CONMED's Outstanding Corporate Bonds
CONMED issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CONMED uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CONMED bonds can be classified according to their maturity, which is the date when CONMED has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand CONMED's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing CONMED's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 2.22 | |||
| Mean Deviation | 1.69 | |||
| Coefficient Of Variation | (1,121) | |||
| Standard Deviation | 2.36 | |||
| Variance | 5.57 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | 0.0392 | |||
| Treynor Ratio | 2.21 | |||
| Maximum Drawdown | 13.79 | |||
| Value At Risk | (3.53) | |||
| Potential Upside | 3.52 | |||
| Skewness | (0.43) | |||
| Kurtosis | 2.87 |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 2.22 | |||
| Mean Deviation | 1.69 | |||
| Coefficient Of Variation | (1,121) | |||
| Standard Deviation | 2.36 | |||
| Variance | 5.57 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | 0.0392 | |||
| Treynor Ratio | 2.21 | |||
| Maximum Drawdown | 13.79 | |||
| Value At Risk | (3.53) | |||
| Potential Upside | 3.52 | |||
| Skewness | (0.43) | |||
| Kurtosis | 2.87 |
Consider CONMED's intraday indicators
CONMED intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CONMED stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
CONMED time-series forecasting models is one of many CONMED's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CONMED's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
CONMED Stock media impact
Far too much social signal, news, headlines, and media speculation about CONMED that are available to investors today. That information is available publicly through CONMED media outlets and privately through word of mouth or via CONMED internal channels. However, regardless of the origin, that massive amount of CONMED data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of CONMED news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of CONMED relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to CONMED's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive CONMED alpha.
CONMED Corporate Directors
| John Workman | Independent Director | Profile | |
| Charles Farkas | Independent Director | Profile | |
| Jerome Lande | Independent Director | Profile | |
| David Bronson | Independent Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CONMED. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CONMED. If investors know CONMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CONMED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CONMED is measured differently than its book value, which is the value of CONMED that is recorded on the company's balance sheet. Investors also form their own opinion of CONMED's value that differs from its market value or its book value, called intrinsic value, which is CONMED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CONMED's market value can be influenced by many factors that don't directly affect CONMED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between CONMED's value and its price, as these two are different measures arrived at by various means. Investors typically determine if CONMED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.